Biotech companies face unique challenges when transitioning from clinical development into GMP-regulated environments. Building compliant structures, managing CDMO partners, and aligning with regulatory expectations often happens under significant time and resource pressure.
Many organizations must establish quality systems and processes from the ground up while advancing toward critical milestones. At the same time, limited GMP expertise and increasing scrutiny from investors and regulators require clear structures, control, and readiness for audits and due diligence.
We support biotech companies in building GMP structures, preparing for scale-up and navigating regulatory and operational complexity from early development to commercial readiness.
Supporting biotech companies in building GMP structures and preparing for the transition from clinical development to commercial manufacturing.
Aligning development and CMC strategies with FDA and EMA expectations to ensure smooth regulatory interactions and submissions.
Designing scalable quality systems tailored to clinical-stage biotech companies — enabling compliant and efficient operations from the start.
Selecting, qualifying, and managing CDMOs to ensure quality, compliance, and operational control across external partners.
Preparing organizations for investor audits, partnerships, and regulatory inspections — ensuring readiness under scrutiny.
Biotech companies often build GMP capabilities under significant time pressure, limited internal expertise, and increasing expectations from regulators, partners and investors. GMP Bridge brings senior-level expertise into these environments supporting the design and implementation of compliant, scalable systems.
Our work is grounded in real GMP practice. We understand how quality systems, CMC requirements, and external manufacturing setups interact and where typical gaps and risks occur. This allows us to establish structures that are not only compliant on paper, but effective in daily operations and defensible during audits.
We support biotech organizations at critical inflection points including GMP build-up, CDMO selection, and preparation for due diligence and inspection scenarios ensuring clear structures, defined responsibilities, and sustainable control.
Biotech is moving fast.Is your GMP strategy keeping up?
We are not focused on billable hours or theoretical frameworks. Every project is led by senior consultants with 20–30 years of hands-on experience in biopharma and advanced therapies manufacturing. We focus on solving critical GMP and Quality problems — quickly and pragmatically — where medicines are made.Â
We specialize in the life sciences sector, with a strong focus on:
Our team’s experience spans the full spectrum of GMP-regulated operations, from early-stage innovation to large-scale commercial supply. We work where medicines are actually made—and where quality and compliance are business-critical.
All our consultants are independent professionals or owners of their own consulting companies, not employees. We contract them through consulting service agreements between their companies and GMP Bridge. This guarantees full legal and tax compliance — without risks of “false self-employment” or similar issues in countries like Germany or Switzerland.
We guarantee a clear and compliant contractual setup, ensuring professional, transparent, and fully legal project delivery.
Both. We support clients at site level, corporate level, or both, depending on the project. Our clients range from global biopharma manufacturers with over 5,000 employees to small biotech startups with as few as 15 people. We adapt to your size, structure, and needs — whether supporting a single production facility or harmonizing processes across multiple international sites.Â
We mobilize quickly. If your situation is urgent, we recommend calling us directly — so we can understand your challenge and assemble the right team without delay.
Depending on your project scope and internal resources, we will decide together how to approach the work. In many cases, we can start within days or one week.
Our structure gives us immediate access to trusted senior consultants — without onboarding delays or lengthy selection processes. Our priority is to help you move forward as fast and effectively as possible.
We are based in Europe, with a strong presence in Germany, Switzerland, and Spain. However, we work globally. Our consultants support clients across North America, and we also manage projects involving suppliers and CDMOs in Asia and Latin America.
Our team includes consultants from multiple nationalities, and we work in languages such as German, Spanish, French, Italian, and Portuguese — ensuring smooth collaboration across regions.